Apixaban versus Warfarin in Patients with Atrial Fibrillation Results of the ARISTOTLE Trial

3049 days ago, 1584 views

PowerPoint PPT Presentation

Foundation. Warfarin is extremely viable at avoiding stroke in patients with atrial fibrillation.Warfarin has a few constraints, including medication and sustenance associations, a restricted restorative reach, requirement for anticoagulation checking, and bleeding.Apixaban is a novel oral element Xa inhibitor with quick retention, a half existence of around 12 hours, and 25% renal elimination.Apixaban has been appeared to r

Presentation Transcript

Slide 1

<html> <head><title>403 Forbidden</title></head> <body> <h1>403 Forbidden</h1> <ul> <li>Code: AccessDenied</li> <li>Message: Access Denied</li> <li>RequestId: S9BQPN6HE1R537G7</li> <li>HostId: COGvBGXosqCviahUiuZgmJdYvg26i1n8sES+eRt5z8qx7EOTEKvDWbhoJhBQbYu1LMTd4kNyRws=</li> </ul> <hr/> </body> </html>

SPONSORS